Status and phase
Conditions
Treatments
About
Study to determine the effect of the investigational drug bezafibrate (BZF) alone and in combination with the investigational drug obeticholic acid (OCA) in participants with Primary Biliary Cholangitis (PBC).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Note: Other protocol defined Inclusion/Exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
60 participants in 5 patient groups
Loading...
Central trial contact
Erminia Cafasso
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal